Physician profile
Seth M Brown
NPI 1679611701
$39,260.64
in general payments reported to CMS, 2019-2025
15 companies · $5,279 in 2025
The $5,279 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $586 · 2021: $214 · 2022: $1,559 · 2023: $1,320 · 2024: $19K · 2025: $5,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $2,973 · Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,868.75 |
| Travel and Lodging | $2,973.13 |
| Food and Beverage | $1,795.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,209.58 | 2021-2025 | Straightshot, Endo-Scrub, Propel |
| Medtronic USA, INC. | $8,685.76 | 2019 | |
| Smith+Nephew, INC. | $2,600.17 | 2019-2020 | |
| Stryker Corporation | $1,381.25 | 2022-2023 | Xpress Ent Dilation System, Latera |
| Intersect Ent, INC. | $329.71 | 2019-2020 | |
| Aerin Medical INC. | $270.37 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $181.68 | 2019-2025 | Dupixent |
| Acclarent, INC | $158.76 | 2019-2023 | Acclarent Navwire |
| Genzyme Corporation | $153.56 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $118.84 | 2023-2025 | Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $89.96 | 2021-2024 | Nucala |
| Karl Storz Endoscopy-America | $24.13 | 2019 | |
| Optinose US, INC. | $22.15 | 2024 | |
| Allergan, INC. | $20.99 | 2019 | |
| Lilly USA, LLC | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.